T. Rowe Price Associates’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.8M | Buy |
1,341,392
+142,339
| +12% | +$8.99M | 0.01% | 608 |
|
|
2025
Q1 | $63.5M | Buy |
1,199,053
+513,901
| +75% | +$27.2M | 0.01% | 651 |
|
|
2024
Q4 | $38.4M | Buy |
685,152
+134,622
| +24% | +$7.54M | ﹤0.01% | 825 |
|
|
2024
Q3 | $28.8M | Buy |
550,530
+24,588
| +5% | +$1.29M | ﹤0.01% | 903 |
|
|
2024
Q2 | $21.6M | Buy |
525,942
+44,409
| +9% | +$1.82M | ﹤0.01% | 950 |
|
|
2024
Q1 | $20.9M | Sell |
481,533
-90,764
| -16% | -$3.93M | ﹤0.01% | 967 |
|
|
2023
Q4 | $26.3M | Buy |
572,297
+361,945
| +172% | +$16.6M | ﹤0.01% | 882 |
|
|
2023
Q3 | $4.82M | Sell |
210,352
-12,885
| -6% | -$295K | ﹤0.01% | 1186 |
|
|
2023
Q2 | $3.68M | Buy |
223,237
+51,657
| +30% | +$852K | ﹤0.01% | 1268 |
|
|
2023
Q1 | $3.06M | Buy |
171,580
+157,380
| +1,108% | +$2.81M | ﹤0.01% | 1319 |
|
|
2022
Q4 | $414K | Sell |
14,200
-2,100
| -13% | -$61.2K | ﹤0.01% | 2221 |
|
|
2022
Q3 | $400K | Buy |
+16,300
| New | +$400K | ﹤0.01% | 2237 |
|
|
2022
Q2 | – | Sell |
-12,900
| Closed | -$149K | – | 3001 |
|
|
2022
Q1 | $149K | Buy |
+12,900
| New | +$149K | ﹤0.01% | 2765 |
|
|
2021
Q4 | – | Sell |
-16,712
| Closed | -$218K | – | 3028 |
|
|
2021
Q3 | $218K | Hold |
16,712
| – | – | ﹤0.01% | 2687 |
|
|
2021
Q2 | $327K | Buy |
16,712
+1,247
| +8% | +$24.4K | ﹤0.01% | 2559 |
|
|
2021
Q1 | $329K | Buy |
15,465
+195
| +1% | +$4.15K | ﹤0.01% | 2526 |
|
|
2020
Q4 | $454K | Buy |
+15,270
| New | +$454K | ﹤0.01% | 2280 |
|
|
2020
Q1 | – | Sell |
-836,985
| Closed | -$19.2M | – | 2553 |
|
|
2019
Q4 | $19.2M | Sell |
836,985
-19,339
| -2% | -$444K | ﹤0.01% | 1196 |
|
|
2019
Q3 | $18.5M | Sell |
856,324
-215,717
| -20% | -$4.66M | ﹤0.01% | 1172 |
|
|
2019
Q2 | $23.6M | Buy |
1,072,041
+64,625
| +6% | +$1.42M | ﹤0.01% | 1133 |
|
|
2019
Q1 | $27.6M | Buy |
1,007,416
+214,142
| +27% | +$5.87M | ﹤0.01% | 1074 |
|
|
2018
Q4 | $21.3M | Buy |
793,274
+3,259
| +0.4% | +$87.6K | ﹤0.01% | 1122 |
|
|
2018
Q3 | $23M | Buy |
790,015
+236,130
| +43% | +$6.89M | ﹤0.01% | 1177 |
|
|
2018
Q2 | $17.3M | Buy |
553,885
+130,836
| +31% | +$4.09M | ﹤0.01% | 1246 |
|
|
2018
Q1 | $8.42M | Buy |
423,049
+118,922
| +39% | +$2.37M | ﹤0.01% | 1361 |
|
|
2017
Q4 | $8.84M | Buy |
+304,127
| New | +$8.84M | ﹤0.01% | 1345 |
|